EBS

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.04
Percentage change 0.50	%

Peers: MRNA SNY NVAX DVAX INBX OCGN VXRT ADMA XERS HEPA

| Held by: VTI AVUV FNDA XBI PRFZ VXF SCHA VHT LABU DFAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.10	Insider Own	4.00%	Shs Outstand	54.10M	Perf Week	-4.48%
Market Cap	441.07M	Forward P/E	4.64	EPS next Y	1.75	Insider Trans	-1.77%	Shs Float	52.02M	Perf Month	-8.78%
Income	-208.80M	PEG	-	EPS next Q	-0.41	Inst Own	58.58%	Short Float	13.32%	Perf Quarter	33.66%
Sales	1.13B	P/S	0.39	EPS this Y	82.99%	Inst Trans	3.38%	Short Ratio	4.40	Perf Half Y	19.65%
Book/sh	9.40	P/B	0.86	EPS next Y	264.62%	ROA	-12.39%	Short Interest	6.93M	Perf Year	263.23%
Cash/sh	2.87	P/C	2.82	EPS next 5Y	-	ROE	-34.64%	52W Range	1.42 - 15.10	Perf YTD	237.50%
Dividend Est.	-	P/FCF	3.19	EPS past 5Y	-	ROI	-17.68%	52W High	-46.36%	Beta	1.64
Dividend TTM	-	Quick Ratio	1.47	Sales past 5Y	10.59%	Gross Margin	28.40%	52W Low	470.42%	ATR (14)	0.61
Dividend Ex-Date	-	Current Ratio	2.88	EPS Y/Y TTM	74.43%	Oper. Margin	-8.03%	RSI (14)	39.30	Volatility	7.03% 5.92%
Employees	1600	Debt/Eq	1.33	Sales Y/Y TTM	1.93%	Profit Margin	-18.55%	Recom	2.33	Target Price	14.00
Option/Short	Yes / Yes	LT Debt/Eq	1.32	EPS Q/Q	140.61%	Payout	-	Rel Volume	1.57	Prev Close	8.06
Sales Surprise	1.19%	EPS Surprise	1226.23%	Sales Q/Q	8.61%	Earnings	Nov 06 AMC	Avg Volume	1.57M	Price	8.10
SMA20	-10.69%	SMA50	-12.64%	SMA200	13.64%	Trades		Volume	2,476,128	Change	0.50%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-22-24	Initiated	Rodman & Renshaw	Buy	$16
Mar-07-24	Upgrade	The Benchmark Company	Hold → Buy	$5
Nov-20-23	Resumed	JP Morgan	Underweight
Aug-29-23	Downgrade	The Benchmark Company	Buy → Hold
Apr-10-23	Upgrade	The Benchmark Company	Hold → Buy	$22
Mar-17-23	Downgrade	JP Morgan	Neutral → Underweight	$23 → $9
Nov-10-22	Downgrade	The Benchmark Company	Buy → Hold
Apr-29-22	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jan-20-22	Upgrade	The Benchmark Company	Hold → Buy	$77
Nov-08-21	Downgrade	The Benchmark Company	Buy → Hold
May-05-21	Downgrade	Argus	Buy → Hold
Apr-07-21	Initiated	The Benchmark Company	Buy	$150
Feb-24-21	Upgrade	Chardan Capital Markets	Neutral → Buy	$112
Feb-19-21	Downgrade	Chardan Capital Markets	Buy → Neutral	$112
Jan-08-21	Downgrade	Wells Fargo	Overweight → Equal Weight	$110
Sep-14-20	Resumed	JP Morgan	Neutral	$103
Jul-31-20	Reiterated	Chardan Capital Markets	Buy	$86 → $112
Sep-12-19	Initiated	Guggenheim	Buy
Sep-04-19	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-02-18	Upgrade	Goldman	Neutral → Buy

Show Previous Ratings

Dec-16-24 08:00AM	Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted) (GlobeNewswire)
Dec-03-24 06:47PM	Why Emergent BioSciences Stock Plummeted Today (Motley Fool) -5.59%
Nov-08-24 10:04AM	Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +7.00%
Nov-07-24 02:06PM	Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024 (Benzinga) +19.57%
01:15AM	Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript (Motley Fool)
06:20PM	Loading…
Nov-06-24 06:20PM	Emergent Biosolutions (EBS) Q3 Earnings Beat Estimates (Zacks)
05:17PM	Emergent Biosolutions: Q3 Earnings Snapshot (Associated Press Finance)
04:49PM	Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa (GlobeNewswire)
04:05PM	Emergent BioSolutions Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-04-24 07:30AM	Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development (GlobeNewswire)
Oct-23-24 07:30AM	Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 (GlobeNewswire) -5.20%
Oct-11-24 12:33PM	Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 (Insider Monkey)
Oct-09-24 05:09PM	Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com) -5.38%
11:09AM	Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says (Pharmaceutical Technology)
Oct-08-24 05:32PM	Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN Nasal Spray to Help Combat the Opioid Epidemic (GlobeNewswire)
07:30AM	Loading…
Oct-02-24 07:30AM	Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility (GlobeNewswire) +8.50%
Sep-26-24 08:05AM	Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA (brincidofovir) to Support National Preparedness Efforts (GlobeNewswire) +22.56%
Sep-25-24 07:07AM	Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts (GlobeNewswire)
Sep-13-24 06:45AM	Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation (GlobeNewswire)
Sep-12-24 08:30AM	Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga Treatment for Ebola (GlobeNewswire)
01:27AM	BlackRock Inc. Reduces Stake in Emergent BioSolutions Inc. (GuruFocus.com)
Sep-04-24 05:51PM	OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing (GlobeNewswire)
08:00AM	Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors (GlobeNewswire)
Sep-03-24 07:08AM	Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile (GlobeNewswire) -11.07%
Aug-30-24 09:55AM	Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine (Barrons.com) -6.73%
08:33AM	This Biotech Stock Surges As WHO Health Emergency Stirs FDA Approval (Investor's Business Daily)
08:33AM	Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine (Investor's Business Daily)
08:16AM	Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness (GlobeNewswire)
04:32AM	Emergent gains FDA approval for ACAM2000 vaccine for Mpox (Pharmaceutical Technology)
Aug-29-24 06:53PM	Emergent BioSolutions' ACAM2000 , (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions (GlobeNewswire)
11:14AM	Loading…
Aug-21-24 11:14AM	Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals (Pharmaceutical Technology) +8.82%
Aug-20-24 12:03PM	Emergent joins mpox fight with 50,000 vaccine dose donation to Africa (Pharmaceutical Technology) -20.33%
11:30AM	Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals (GlobeNewswire)
Aug-19-24 05:16PM	WHO declares mpox a public health emergency as variant emerges (Yahoo Finance Video) +12.66%
05:10PM	Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa (GlobeNewswire)
Aug-16-24 04:14PM	Emergent Leads Mpox-Tied Stock Gains as Investors Await Approval (Bloomberg) +24.02%
12:51PM	Why Emergent BioSolutions Stock Is Skyrocketing Today (Motley Fool)
09:52AM	Mpox Vaccine Makers Stock Soars After Fresh WHO Warning (Barrons.com)
Aug-07-24 02:45AM	Emergent BioSolutions (EBS) Q2 2024 Earnings Call Transcript (Motley Fool) -41.99%
Aug-06-24 05:14PM	Emergent Biosolutions: Q2 Earnings Snapshot (Associated Press Finance)
05:01PM	Emergent BioSolutions Reports Second Quarter 2024 Financial Results (GlobeNewswire)
08:00AM	Emergent BioSolutions Expands NARCAN Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country (GlobeNewswire)
Jul-31-24 09:06AM	SERB Pharmaceuticals strengthens leadership in medical countermeasures with the global acquisition of RSDL (Reactive Skin Decontamination Lotion) kit for $75 million (GlobeNewswire) +7.08%
08:53AM	Emergent BioSolutions Completes Sale of RSDL (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million (GlobeNewswire)
Jul-25-24 01:20PM	The stock markets cruel summer is about to get much worse (MarketWatch)
Jul-24-24 07:30AM	Emergent BioSolutions Launches Opioid Emergency Preparedness 'Lay, Spray, Stay' Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith (GlobeNewswire) +10.57%
Jul-23-24 08:27AM	Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024 (GlobeNewswire) +8.99%
Jul-22-24 08:00AM	Emergent BioSolutions Announces Shelf-Life Extension for NARCAN Nasal Spray in Canada (GlobeNewswire)
Jul-09-24 07:30AM	Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan (GlobeNewswire) +7.26%
Jul-03-24 10:13AM	Emergent scores US medical countermeasure contracts worth over $250m (Pharmaceutical Technology)
Jul-02-24 09:43AM	Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products (GlobeNewswire) +6.09%
08:13AM	Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products (GlobeNewswire)
Jun-24-24 06:35AM	7 Top Stocks Under $10: June 2024 Edition (InvestorPlace)
Jun-21-24 06:53AM	Emergent to sell US sterile manufacturing facility to Bora (Pharmaceutical Technology)
Jun-20-24 07:00AM	Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million (GlobeNewswire) +6.77%
Jun-06-24 09:02AM	Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day (GlobeNewswire) -6.15%
May-21-24 07:00AM	7 Stocks to Buy Immediately Following Strong Earnings (InvestorPlace) -10.69%
May-16-24 04:09PM	Vice Stock Vanguards: 3 Sin Stocks Delivering Heavenly Returns (InvestorPlace) -7.71% +5.31%
May-10-24 07:17AM	Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 (GlobeNewswire)
May-02-24 01:48PM	Top Midday Gainers (MT Newswires) +70.98%
12:33PM	Q1 2024 Emergent BioSolutions Inc Earnings Call (Thomson Reuters StreetEvents)
12:10PM	MercadoLibre Stock Split: Will MELI Investors See Wishes Come True Today? (InvestorPlace)
11:27AM	JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock (InvestorPlace)
11:13AM	Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts (InvestorPlace)
10:38AM	Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM	Top Premarket Gainers (MT Newswires)
07:58AM	Why Is Emergent BioSolutions (EBS) Stock Up 57% Today? (InvestorPlace)
07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
03:54AM	Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ... (GuruFocus.com)
12:42AM	PRESS DIGEST- Wall Street Journal - May 2 (Reuters)
May-01-24 11:45PM	Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript (Motley Fool)
10:56PM	EBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:15PM	Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ... (GuruFocus.com)
05:53PM	Emergent Biosolutions: Q1 Earnings Snapshot (Associated Press Finance)
05:52PM	Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities (The Wall Street Journal)
04:57PM	Emergent BioSolutions Reports First Quarter 2024 Financial Results (GlobeNewswire)
04:34PM	UPDATE 2-Emergent BioSolutions to lay off about 300 employees (Reuters)
04:21PM	Emergent BioSolutions to cut 300 jobs (Reuters)
04:10PM	Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position (GlobeNewswire)
11:03AM	Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone (GlobeNewswire)
Apr-30-24 05:26PM	Emergent BioSolutions Announces Amendment to its Existing Credit Facility (GlobeNewswire)
Apr-22-24 08:05AM	Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024 (GlobeNewswire) +5.88%
Apr-01-24 08:00AM	Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive (GlobeNewswire) -9.09%
Mar-28-24 08:15AM	Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis (GlobeNewswire)
Mar-25-24 08:05AM	Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility (GlobeNewswire) +5.39%
Mar-07-24 01:58PM	Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com) -15.03%
12:34PM	Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales (Zacks)
10:33AM	Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:35AM	Q4 2023 Emergent BioSolutions Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-06-24 11:30PM	Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript (Motley Fool)
09:53PM	EBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:55PM	Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:20PM	Emergent Biosolutions: Q4 Earnings Snapshot (Associated Press Finance)
04:31PM	Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results (GlobeNewswire)
Feb-29-24 07:00AM	Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024 (GlobeNewswire)
Feb-21-24 03:24PM	Why Is Emergent BioSolutions (EBS) Stock Up 70% Today? (InvestorPlace) +78.29%
07:35AM	UPDATE 2-Emergent appoints former Bausch + Lomb CEO to head company (Reuters)
07:06AM	Emergent names Joseph Papa as new CEO (Reuters)
07:00AM	Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO (GlobeNewswire)
Jan-17-24 11:55AM	Emergent extends shelf life of opioid overdose reversal drug Narcan (Reuters) -5.42%

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DeGolyer Donald W	Director	Nov 12 '24	Sale	10.91	25,000	272,750	111,100	Nov 14 04:18 PM
White Marvin L	Director	Nov 11 '24	Sale	11.97	14,287	171,015	54,092	Nov 13 04:04 PM
DeGolyer Donald W	Director	Nov 12 '24	Proposed Sale	11.77	25,000	294,250		Nov 12 05:16 PM
White Marvin L	Director	Nov 11 '24	Proposed Sale	11.77	14,287	168,158		Nov 12 10:34 AM
Zoon Kathryn C	Director	Jun 04 '24	Sale	6.11	10,000	61,100	54,482	Jun 06 04:16 PM
Zoon Kathryn C	Director	May 29 '24	Sale	4.61	1,830	8,436	64,482	May 31 03:02 PM
Zoon Kathryn C	Director	May 21 '24	Sale	5.78	1,089	6,294	48,882	May 23 05:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Emergent Biosolutions Inc

Upgrade your FINVIZ experience